U.S. federal trademark · Serial No. 99123382
Pharmaceutical research and development for neurodevelopment disorders
Small molecule therapeutic pharmaceuticals for the treatment of neurodevelopmental disorders, namely, attention deficit hyperactivity disorder (ADHD), autism spectrum disorders, and Down syndrome
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.